Related Experiment Video
Updated: Feb 2, 2026

Methods to Discover Alternative Promoter Usage and Transcriptional Regulation of Murine Bcrp1
Published on: May 27, 2016
Inhibition of STAT5A promotes osteogenesis by DLX5 regulation
Kyoung-Mi Lee1,2, Kwang Hwan Park1, Ji Suk Hwang1
1Department of Orthopaedic Surgery, Yonsei University College of Medicine, 50-1 Yonsei -ro, Seodaemun-gu, Seoul, 03722, South Korea.
Abstract:
The regulation of osteogenesis is important for bone formation and fracture healing. Despite advances in understanding the molecular mechanisms of osteogenesis, crucial modulators in this process are not well-characterized. Here we demonstrate that suppression of signal transducer and activator of transcription 5A (STAT5A) activates distal-less homeobox 5 (DLX5) in human bone marrow-derived stromal cells (hBMSCs) and enhances osteogenesis in vitro and in vivo. We show that STAT5A negatively regulates expression of Dlx5 in vitro and that STAT5A deletion results in increased trabecular and cortical bone mass and bone mineral density in mice. Additionally, STAT5A deletion prevents age-related bone loss. In a murine fracture model, STAT5A deletion was found to significantly enhance bone remodeling by stimulating the formation of a fracture callus. Our findings indicate that STAT5A inhibition enhances bone formation by promoting osteogenesis of BMSCs.
Insights
Inhibiting signal transducer and activator of transcription 5A (STAT5A) boosts bone formation by activating distal-less homeobox 5 (DLX5). This discovery enhances osteogenesis, crucial for bone repair and preventing bone loss.
Area of Science:
- Bone Biology
- Molecular Mechanisms of Osteogenesis
- Cellular Regulation
Background:
- Osteogenesis regulation is vital for bone formation and fracture healing.
- Key molecular regulators of osteogenesis remain incompletely understood.
- Signal transducer and activator of transcription 5A (STAT5A) role in bone is not well-defined.
Purpose of the Study:
- To investigate the role of STAT5A in osteogenesis.
- To determine if STAT5A influences distal-less homeobox 5 (DLX5) expression.
- To evaluate the therapeutic potential of STAT5A inhibition in bone disorders.
Main Methods:
- Utilized human bone marrow-derived stromal cells (hBMSCs) for in vitro studies.
- Employed STAT5A knockout mouse models for in vivo experiments.
- Assessed bone mass, bone mineral density, and fracture healing in murine models.
Main Results:
- STAT5A suppression activates DLX5 expression in hBMSCs.
- STAT5A deletion in mice leads to increased trabecular and cortical bone mass.
- STAT5A deficiency prevents age-related bone loss and enhances fracture callus formation.
Conclusions:
- STAT5A acts as a negative regulator of osteogenesis.
- STAT5A inhibition promotes osteogenesis by activating DLX5.
- Targeting STAT5A represents a potential strategy for treating bone loss and improving fracture healing.
More Related Videos
Related Concept Videos
The Eukaryotic Promoter Region
Master Transcription Regulators
Feedback Inhibition
Epigenetic Regulation
Positive Regulator Molecules
Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...

